SSM Stock: price and insider trades · Australia

SSM is a Health Care company. Its directors and officers file their transactions with ASX. The last twelve months, up to 18 October 2026, brought 10 filings signed by 9 insiders.

The record shows 1 purchase on the open market worth €6,041, made by 1 insider, against 1 sale worth €1.8M by 1 insider. Taken together, the sales exceed the purchases by €1.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a sale of €1.8M, published on 29 September 2026. Those buying include 1 senior executive.

With 10 filings in twelve months, the company is more active than the median of 3 filings across the 2,530 companies we follow on the same exchange. Our records for SSM go back to 2026, with 1 purchase and 1 sale on the open market in total.

The clock since the last published purchase (24 April 2026) now reads 177 days. The median gap between a trade and its publication by ASX is 4 days. That lag is the time during which only the insider knows about the trade.

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.